Position history for BAKER BROS. ADVISORS LP's holdings in ABCELLERA BIOLOGICS INC
BAKER BROS. ADVISORS LP holds 30.3M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $105.7M as of 2026-Q1. The position was increased (+10.0% shares). ABCL represents 0.6% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$105.7M
Current Shares
30.3M
Total Value Change
+$24.2M
Total Shares Change
+2.8M
Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, Capital World Investors, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 30.3M |
+10.0% |
| $105.7M |
| 0.6% |
| $3.71 |
47 |
| 2025-Q4 | Unchanged | 27.5M | 0.0% | $94.1M | 0.6% | $3.45 | 0 |
| 2025-Q3 | Unchanged | 27.5M | 0.0% | $138.5M | 1.0% | $4.87 | 0 |
| 2025-Q2 | Unchanged | 27.5M | 0.0% | $94.4M | 0.9% | $3.61 | 0 |
| 2025-Q1 | Unchanged | 27.5M | 0.0% | $61.4M | 0.7% | $2.31 | 0 |
| 2024-Q4 | Unchanged | 27.5M | 0.0% | $80.7M | 0.9% | $2.82 | 0 |
| 2024-Q3 | Unchanged | 27.5M | 0.0% | $71.6M | 0.7% | $2.61 | 0 |
| 2024-Q2 | Unchanged | 27.5M | 0.0% | $81.5M | 1.0% | $2.96 | 0 |